The Metformin versus Insulin for the treatment of Gestational diabetes (MiG) study was an Australian off-label randomized trial including 751 women with GDM at 20 to 33 weeks of gestation to open treatment with metformin (373/751 patients) or insulin (378/751 patients). Here, INS is linked to gestational diabetes.